<MedlineCitation Owner="HSR" Status="Completed">
		<MedlineID>21978178</MedlineID>
		<PMID>11982031</PMID>
		<DateCreated>
			   <Year>2002</Year>
			   <Month>04</Month>
			   <Day>30</Day>
		</DateCreated>
		<DateCompleted>
			   <Year>2002</Year>
			   <Month>05</Month>
			   <Day>09</Day>
		</DateCompleted>
		<Article>
			   <Journal>
				     <ISSN>0097-6326</ISSN>
				     <JournalIssue>
					       <Volume>67</Volume>
					       <Issue>83</Issue>
					       <PubDate>
						         <Year>2002</Year>
						         <Month>Apr</Month>
						         <Day>30</Day>
					       </PubDate>
				     </JournalIssue>
			   </Journal>
			   <ArticleTitle>Orthopedic devices: reclassification of the hip joint metal/polymer
				constrained cemented or uncemented prosthesis. Final Rule.</ArticleTitle>
			   <Pagination>
				     <MedlinePgn>21171-3</MedlinePgn>
			   </Pagination>
			   <Abstract>
				     <AbstractText>The Food and Drug Administration (FDA) is reclassifying the hip joint
					metal/polymer constrained cemented or uncemented prosthesis intended to replace
					a hip joint from class III (premarket approval) to class II (special controls).
					FDA is also [[Page 21172]] identifying the guidance document entitled "Class II
					Special Controls Guidance Document: Hip Joint Metal/Polymer Constrained Cemented
					or Uncemented Prosthesis" as the special control that the agency believes will
					reasonably ensure the safety and effectiveness of the device. This
					reclassification is being undertaken based on new information regarding the
					device contained in a reclassification petition submitted by the Orthopedic
					Surgical Manufacturers Association (OSMA), under the Federal Food, Drug, and
					Cosmetic Act (the act), as amended by the Medical Device Amendments of 1976 (the
					1976 Amendments), the Safe Medical Devices Act of 1990 (SMDA), and the Food and
					Drug Administration Moderization Act of 1997 (FDAMA). FDA is also revising the
					device identification to accurately describe the device.</AbstractText>
			   </Abstract>
			   <AuthorList CompleteYN="Y">
				     <Author>
					       <CollectiveName>Food and Drug Administration, HHS</CollectiveName>
				     </Author>
			   </AuthorList>
			   <Language>eng</Language>
			   <PublicationTypeList>
				     <PublicationType>Journal Article</PublicationType>
			   </PublicationTypeList>
		</Article>
		<MedlineJournalInfo>
			   <Country>United States</Country>
			   <MedlineTA>Fed Regist</MedlineTA>
			   <NlmUniqueID>7808722</NlmUniqueID>
		</MedlineJournalInfo>
		<CitationSubset>T</CitationSubset>
		<MeshHeadingList>
			   <MeshHeading>
				     <DescriptorName MajorTopicYN="Y">Device Approval</DescriptorName>
				     <QualifierName MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
			   </MeshHeading>
			   <MeshHeading>
				     <DescriptorName MajorTopicYN="N">Equipment Design</DescriptorName>
			   </MeshHeading>
			   <MeshHeading>
				     <DescriptorName MajorTopicYN="N">Equipment Safety</DescriptorName>
			   </MeshHeading>
			   <MeshHeading>
				     <DescriptorName MajorTopicYN="N">Hip Prosthesis</DescriptorName>
				     <QualifierName MajorTopicYN="Y">classification</QualifierName>
			   </MeshHeading>
			   <MeshHeading>
				     <DescriptorName MajorTopicYN="N">Human</DescriptorName>
			   </MeshHeading>
			   <MeshHeading>
				     <DescriptorName MajorTopicYN="N">United States</DescriptorName>
			   </MeshHeading>
			   <MeshHeading>
				     <DescriptorName MajorTopicYN="N">United States Food and Drug
					Administration</DescriptorName>
			   </MeshHeading>
		</MeshHeadingList>
	</MedlineCitation>